必应词典为您提供multikinase-inhibitor的释义,网络释义: 多激酶抑制剂;激酶抑制剂;
multikinase inhibitorhuman head and neck squamous cell carcinoma (HNSCC)tissue microarrayBackground. Radioresistance is a common feature of head and neck squamous cell carcinoma (HNSCC). We previously showed that the irradiation-activated vascular endothelial growth factor (VEGF)-extracellular signal-...
Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinoma. Expert Rev Anticancer Ther 2010;10: 635-645.Bukowski RM (2010) Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinoma. Expert Rev Anticancer Ther 10:635-645...
Multikinase Inhibitor Ct-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated Igf-1r-Yap Axis 类型: 作者:Zhu, H., Wang, D. D., Yuan, T., Yan, F. J., Zeng, C. M., Dai, X. Y., Chen, Z. B., Chen, Y., Zhou, T., Fan, G. H., Ying, M., Cao, J., Luo, ...
The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cells. Huang R, Chen XQ, Huang Y, Chen N, Zeng H (2010) The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cells... Rui,Huang,Xue-Qin,... - 《Asian ...
Methods: In this investigation, we assessed the in vitro and in vivo anti-melanoma activities of SC-535, which is a novel small molecule multikinase inhibitor discovered by us recently. We analyzed inhibitory effects of SC-535 on various melanoma cell lines and human umbilical vascular endothelial...
Ponatinib is a small molecule multi‐tyrosine kinase inhibitor clinically approved for anticancer therapy. Molecular mechanisms by which cancer cells develop resistance against ponatinib are currently poorly understood. Likewise, intracellular drug dynamics, as well as potential microenvironmental factors ...
Regorafenib is a multikinase inhibitor with anti-vascular endothelial growth factor receptor (VEGF) activity used as an antiangiogenic agent for metastatic colorectal cancer treatment and has been studied as a potential therapeutic agent for several other cancer treatments. Adverse reactions commonly ...
The multikinase inhibitor sorafenib may stand for a new therapeutic approach. Methods:To evaluate the effect of sorafenib on different HB cell lines MTT-/Caspase 3-Assay was performed. Sorafenib was administered orally to NMRI mice ... H Goto,T Sarashina,D Keino,... - 《Pediatric Blood & Ca...
MULTIKINASE INHIBITOR COMPOUND AND ITS CRYSTALLINE FORM AND USE 发明人: УФрэнк;УФрэнкWUFrank 申请人: 申请日期: 2017-12-12 申请公布日期: 2020-06-18 代理机构: 代理人: 地址: 摘要: FIELD: chemistry.SUBSTANCE: present invention refers to a compound of formula (I), or its...